69 related articles for article (PubMed ID: 19145073)
1. High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.
Tyralla K; Adamczak M; Benz K; Campean V; Gross ML; Hilgers KF; Ritz E; Amann K
PLoS One; 2011 Jan; 6(1):e15287. PubMed ID: 21298056
[TBL] [Abstract][Full Text] [Related]
2. Metastatic calcification from secondary hyperparathyroidism.
Cheng K; Li J; Liu X
Am J Med Sci; 2024 Mar; ():. PubMed ID: 38460923
[No Abstract] [Full Text] [Related]
3. Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder.
Larivière R; Ung RV; Picard S; Richard DE; Mac-Way F; Agharazii M
Front Cardiovasc Med; 2023; 10():1241943. PubMed ID: 37840953
[TBL] [Abstract][Full Text] [Related]
4. User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study : ACEI/ARB and vascular calcification.
Takaori K; Iwatani H; Yamato M; Ito T
BMC Nephrol; 2021 Jan; 22(1):7. PubMed ID: 33407242
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function.
Hénaut L; Mary A; Chillon JM; Kamel S; Massy ZA
Toxins (Basel); 2018 May; 10(6):. PubMed ID: 29844272
[TBL] [Abstract][Full Text] [Related]
6. Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients.
Shang D; Xie Q; Shang B; Zhang M; You L; Hao CM; Zhu T
Biomed Res Int; 2017; 2017():2520510. PubMed ID: 28321403
[No Abstract] [Full Text] [Related]
7. Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature.
Byon CH; Chen Y
Curr Osteoporos Rep; 2015 Aug; 13(4):206-15. PubMed ID: 25947259
[TBL] [Abstract][Full Text] [Related]
8. Sevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease.
Perry CM; Plosker GL
Drugs; 2014 May; 74(7):771-92. PubMed ID: 24811546
[TBL] [Abstract][Full Text] [Related]
9. Vascular calcification: pathophysiology and risk factors.
Chen NX; Moe SM
Curr Hypertens Rep; 2012 Jun; 14(3):228-37. PubMed ID: 22476974
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of vascular calcification - a systematic review.
Karwowski W; Naumnik B; Szczepański M; Myśliwiec M
Med Sci Monit; 2012 Jan; 18(1):RA1-11. PubMed ID: 22207127
[TBL] [Abstract][Full Text] [Related]
11. Klotho deficiency causes vascular calcification in chronic kidney disease.
Hu MC; Shi M; Zhang J; Quiñones H; Griffith C; Kuro-o M; Moe OW
J Am Soc Nephrol; 2011 Jan; 22(1):124-36. PubMed ID: 21115613
[TBL] [Abstract][Full Text] [Related]
12. Novel markers of left ventricular hypertrophy in uremia.
Nakamura H; Tokumoto M; Mizobuchi M; Ritter CS; Finch JL; Mukai M; Slatopolsky E
Am J Nephrol; 2010; 31(4):292-302. PubMed ID: 20130393
[TBL] [Abstract][Full Text] [Related]
13. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K; Tanaka M; Hashiguchi J; Funakoshi S; Nakano H; Kubo H; Kono T; Uchino J; Masaki K; Date T; Shigematsu T;
Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Koizumi M; Fukagawa M
Clin Calcium; 2010 Nov; 20(11):1700-8. PubMed ID: 21037391
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
Tokumoto M; Mizobuchi M; Finch JL; Nakamura H; Martin DR; Slatopolsky E
Am J Nephrol; 2009; 29(6):582-91. PubMed ID: 19145073
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
